The combined company will operate under the Spinal Stabilization Technologies name and be listed on the stock exchange. Spinal Stabilization Technologies is known for its lumbar intervertebral disc nucleus replacement device.
The deal is expected to close in the fourth quarter of 2023 or in early 2024. The company would have an estimated $302 million enterprise value post-transaction.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
